REDUCTION OF SERUM-LIPIDS BY MEANS OF ETIROXATE (LIPONORM)

被引：8

作者：

LAGEDER, H

IRSIGLER, K

机构：

[1] UNIV VIENNA,DEPT INTERN MED 1,VIENNA,AUSTRIA

[2] UNIV VIENNA,SECT METAB & NUTR,VIENNA,AUSTRIA

来源：

ATHEROSCLEROSIS | 1975年 / 22卷 / 03期

关键词：

D O I：

10.1016/0021-9150(75)90026-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：473 / 484

页数：12

相关论文

共 28 条

[1] BECKMANN R, 1972, PHARMACOLOGICAL CONT, V26, P276
[2] BUCHWALD H, 1974, CIRCULATION S1, V44
[3] CARLSON LA, 1960, ACTA MED SCAND, V167, P399
[4] APPRAISAL AND REAPPRAISAL OF DRUGS USED IN TREATMENT OF HEART CONDITIONS
DEGRAFF, AC
[J]. AMERICAN HEART JOURNAL, 1963, 65 (01) : 131 - &
[5] FAMILIAL FACTORS IN PREMATURE CORONARY HEART DISEASE - A PRELIMINARY REPORT FROM TECUMSEH COMMUNITY HEALTH STUDY
DEUTSCHER, S
OSTRANDER, LD
EPSTEIN, FH
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1970, 91 (03) : 233 - +
[6] GLOBEL B, IN PRESS
[7] GRIES FA, 1972, PHARMACOLOGICAL CONT, V26, P297
[8] HAYES D, 1964, CLIN SCI, V26, P185
[9] SODIUM DEXTRO-THYROXINE IN CORONARY DISEASE AND HYPERCHOLESTEREMIA
JONES, RJ
COHEN, L
[J]. CIRCULATION, 1961, 24 (02) : 164 - &
[10] FACTORS OF RISK IN DEVELOPMENT OF CORONARY HEART DISEASE - 6-YEAR FOLLOW-UP EXPERIENCE
KANNEL, WB
KAGAN, A
STOKES, J
DAWBER, TR
REVOTSKIE, N
[J]. ANNALS OF INTERNAL MEDICINE, 1961, 55 (01) : 33 - +